
PROTOCOL’s latest findings reveal a critical gap in preventive health, where hidden biomarker risks remain undetected in routine screenings despite affecting high-performing professionals.
Backed by US$1m in pre-seed funding, the company is addressing this gap through data-driven diagnostics built on insights from over 1,000 blood tests at its Singapore clinic.
Explore PROTOCOL’s approach to early risk detection: bit.ly/4vX8P0J
#SingaporeBusinessReview #PROTOCOL
English